3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid

3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid Basic information
Description Appearance
Product Name:3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid
Synonyms:3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid;(3-Oxo-1,3-dihydroisobenzofuran-1-yl)phosphonic acid dimethyl ester;Dimethyl (3-oxo-1,3-dihydroisobenzofuran-1-yl)phosphonate;Phosphonic acid, (1,3-dihydro-3-oxo-1-isobenzofuranyl)-, diMethyl ester;Dimethyl (1,3-dihydro-3-oxo-1-isobenzofuranyl)phosphonate;Phosphonic acid,P-(1,3-dihydro-3-oxo-1-isobenzofuranyl)-,dimethyl ester;dimethyl 1,3-dihydro-3-oxoisobenzofuran-1-yl-1-phosphonate;3-dimethoxyphosphoryl-3H-2-benzofuran-1-one
CAS:61260-15-9
MF:C10H11O5P
MW:242.17
EINECS:
Product Categories:
Mol File:61260-15-9.mol
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid Structure
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid Chemical Properties
Melting point 97-99℃
Boiling point 402.0±45.0 °C(Predicted)
density 1.35
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
form solid
color White
Safety Information
HS Code 2932990090
MSDS Information
3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid Usage And Synthesis
Description3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid can be used as a pharmaceutical intermediate for pharmaceutical synthesis experiments.
AppearanceWhite crystal
UsesDimethyl (3-oxo-1,3-dihydroisobenzofuran-1-yl)phosphonate is a reagent used in the synthesis of 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one, an inhibitor of both PARP-1 AND PARP-2 that shows standalone activity against BRCA1-deficient breast cancer cell lines.
SynthesisSodium methoxide (2.28 g,0.042 mol) was dissolved in methanol (40 mL) into a 150 mLround-bottom flask. To this solution, dimethyl hydrogen phosphite(4.8 mL, 0.049 mol) and 2-carboxybenzaldehyde (compound5, 5.00 g, 0.033 mol) were added by dripping at 0 °Cfor 30 min. Then the mixture was stirred at room temperaturefor 8 h.
After the reaction was completed, methanesulfonicacid (3.1 mL, 0.047 mol) was added dropwise and stirred for30 min. The solvent was removed under reduced pressure,following by adding 40 mol water.
The aqueous phase wasextracted with dichloromethane for three times, the combinedorganic phase was washed with water until neutral and driedwith anhydrous sodium sulfate. Dichloromethane was evaporatedunder reduced pressure to afford 3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid(4.93 g, 99%)as white solid.
1H-NMR (500 MHz, DMSO-d6) δ: 3.62 (3H,d, J = 8 Hz), 3.86 (3H, d, J = 12 Hz), 6.36 (1H, d, J = 8 Hz),7.74-7.70 (2H, m), 7.91-7.88 (1H, m), 7.98-7.96 (1H, m).
Synthesis of 3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid
Olaparib 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride PIPERAZINE DIHYDROCHLORIDE 3-((4-Oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid Olaparib impurity 1 Olaparib Impurity 22 Olaparib Metabolite M12 2-Bromopropane Olaparib Imp.2 1-(CYCLOPROPANECARBONYL)PIPERAZINE 97 5-Bromo-2-fluorobenzonitrile 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzonitrile 2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate tert-butyl 4-(cyclopropylcarbonyl)-1-piperazinecarboxylate Cyclopropanecarboxylic acid 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.